French Register Of Patients With Hemopathy Eligible For CAR-T Cell Treatment (DESCAR-T)

Recruiting now

Conditions studied: Hematopathology Eligible or CAR-t Cell Treatment

In brief

This study is a registry including prospective and retrospective data on all patients who have been presented in a Multidisciplinary tumor board or RCP to be eligible for CAR-T cell treatment.

Key facts

Study ID

NCT04328298

Run by

The Lymphoma Academic Research Organisation

People needed

5000

Starts

2019-12-19

Expected to finish

2038-12-19

Last updated by the study team

2026-03-04

Who can join

Age: any, up to 99. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Retrospective inclusion :
• Patient treated with CAR-T from 1 July 2018 under temporary authorization (ATU) or covered by French health insurance system (under post-ATU or MA) in a qualified center before activation of this register in this center
• If the patient is alive, the patient has been informed of the collection and use of their data, and the patient has not opposed this use. If the patient has died, the patient did not opposed the use of their data while alive
• Prospective inclusion :
• Patient eligible for a treatment with CAR-T for an hematological malignancy which is covered by French health insurance (for ATUs / post-ATUs or MA), or as part of a clinical trial with the same indication, after the activation of this register in this center.
• Patient whose CAR-T indication has been validated during a multidisciplinary tumor board (RCP) of a qualified center, according to the ministerial order of 8 August 2019
• Patient deemed eligible for a treatment with CAR-T after a medical exam performed in a qualified center according to the ministerial order of 8 August 2019
• If the patient is alive, the patient has been informed of the collection and use of their data, and the patient has not opposed this use. If the patient has died, the patient did not opposed the use of their data while alive.
• Exclusion Criteria Patient not registered with the social security in France

Where it is running

• CHU d'Amiens - Hôpital Sud — Amiens, France (enrolling)
• CHU Angers — Angers, France (enrolling)
• CHRU Besançon - Hôpital Minjoz — Besançon, France (enrolling)
• CHU de Brest - Hôpital du Morvan — Brest, France (enrolling)
• Institut d'Hématologie de Basse Normandie — Caen, France (enrolling)
• CHU d'Estaing — Clermont-Ferrand, France (enrolling)
• APHP - Hôpital Henri Mondor — Créteil, France (enrolling)
• CHU de Dijon — Dijon, France (enrolling)
• CHU de Grenoble — La Tronche, France (enrolling)
• CHRU de Lille - Hôpital Claude Hurriez — Lille, France (enrolling)
• Hôpital Dupuytren — Limoges, France (enrolling)
• Centre Léon Bérard — Lyon, France (enrolling)
• Institut d'Hématologie et d'Oncologie Pédiatrique (IHOP) — Lyon, France (enrolling)
• Hôpital de la Timone — Marseille, France (enrolling)
• Institut Paoli Calmette — Marseille, France (enrolling)
• CHU de Montpellier — Montpellier, France (enrolling)
• CHU de Nantes - Hôtel Dieu — Nantes, France (enrolling)
• CHU de Nice — Nice, France (enrolling)
• APHP - Hôpital Cochin — Paris, France (enrolling)
• APHP - Hôpital La Pitié Salpêtrière — Paris, France (enrolling)
• APHP - Hôpital Necker — Paris, France (enrolling)
• APHP - Hôpital Saint Antoine — Paris, France (enrolling)
• APHP - Hôpital Saint Louis — Paris, France (enrolling)
• APHP - Hôpital Universitaire Robert Debré — Paris, France (enrolling)
• Centre Francois Magendie — Pessac, France (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.